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Background. Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the 
accumulation of periodic acid-Schiff (PAS)-positive lipoproteinaceous material within the 
alveoli resulting in hypoxemic respiratory failure. Secondary PAP due to heavy inhalation 
exposure to inorganic dusts causes a reduction in the number and clearance capacity of alveolar 
macrophages.  
Case report. We present you the case of a 42-year-old Sudanese patient with a 17-pack years 
smoking history who shows up at the hospital in December 2019 for dry cough, weight loss 
and exertional dyspnea. The onset of the symptoms started 2 months earlier, after using 
sandpaper on the walls while refurbishing his house.  The initial diagnosis based on the clinical 
context and chest X-ray was pulmonary tuberculosis. However, the Acid-Fast Bacillus (AFB) 
smear was negative and the High-resolution CT showed a “crazy-paving” pattern. The blood 
count showed no evidence of hematologic malignancy or myelodysplastic syndrome. A 
flexible bronchoscopy to obtain bronchoalveolar lavage (BAL) fluid was performed. The 
examination of the BAL fluid showed the presence of PAS-positive material and the growth of 
E.coli colonies with no atypical cells found. Pulmonary function tests demonstrated a moderate 
reduction in the diffusing capacity for carbon monoxide (DLCO).  : Using all of the findings, 
the diagnosis of secondary pulmonary alveolar proteinosis was established. The patient 
received antibiotic treatment with ceftriaxone and ciprofloxacin. Whole lung lavage under 
general anesthesia via a double-lumen endotracheal tube was performed, which proved to be 
effective. The patient was advised to stop smoking and a regular check twice a year was 
recommended.  
Conclusions. Secondary PAP represents less than 10% of the total cases of pulmonary 
proteinosis. Further tests should be performed to identify the exact etiology in this situation 
The particularity of the case comes from the short exposure to the toxic, as well as its ethnic 
background.  
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